These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1518390)

  • 1. Inhibition of myocardial lipoprotein lipase by U-57,908 (RHC 80267).
    Carroll R; Severson DL
    Lipids; 1992 Apr; 27(4):305-7. PubMed ID: 1518390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of diacylglycerol metabolism in isolated cardiac myocytes by U-57 908 (RHC 80267), a diacylglycerol lipase inhibitor.
    Chuang M; Severson DL
    J Mol Cell Cardiol; 1990 Sep; 22(9):1009-16. PubMed ID: 2177792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucose-induced insulin secretion by the diacylglycerol lipase inhibitor RHC 80267 and the phospholipase A2 inhibitor ACA through stimulation of K+ permeability without diminution by exogenous arachidonic acid.
    Thams P; Capito K
    Biochem Pharmacol; 1997 Apr; 53(8):1077-86. PubMed ID: 9175712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity.
    Rodrigues B; Spooner MR; Severson DL
    Mol Cell Biochem; 1992 Oct; 116(1-2):33-7. PubMed ID: 1480152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
    Severson DL; Lee M; Carroll R
    Mol Cell Biochem; 1988 Jan; 79(1):17-24. PubMed ID: 3374475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lipoprotein lipase activity in heart myocytes and perfused hearts.
    Bagby GJ; Corll CB
    J Mol Cell Cardiol; 1989 Mar; 21(3):253-62. PubMed ID: 2746652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolated myocardial cells from rat heart.
    Ramírez I; Severson DL
    Biochem J; 1986 Aug; 238(1):233-8. PubMed ID: 3800935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
    Oglesby TD; Gorman RR
    Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart.
    Ramírez I; Kryski AJ; Ben-Zeev O; Schotz MC; Severson DL
    Biochem J; 1985 Nov; 232(1):229-36. PubMed ID: 4084231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of heparin-releasable lipase and tissue neutral lipase activity of rat heart.
    Stam H; Hülsmann WC
    Biochem Int; 1983 Aug; 7(2):187-95. PubMed ID: 6679339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE; Severson DL
    Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of myocardial lipase by palmityl CoA.
    McDonough KH; Neely JR
    J Mol Cell Cardiol; 1988 Mar; 20 Suppl 2():31-9. PubMed ID: 3411615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RHC 80267 inhibits thyrotropin-stimulated prostaglandin release from rat thyroid lobes.
    Levasseur S; Kostelec M; Burke G
    Prostaglandins; 1984 May; 27(5):673-82. PubMed ID: 6431499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.